News from the Regions in Structural Change | Nov 2022
Germany's regions in structural change are proving attractive with international investors, with numerous new developments announced in recent months.
Your company is already operating in Germany and you would now like to export worldwide?
Germany's regions in structural change are proving attractive with international investors, with numerous new developments announced in recent months.
Germany's biotechnology industry is thriving. Revenues more than tripled in 2021 compared to the previous record year 2020. In 2021, the number of biotechnology companies in Germany increased to over 774.
Germany's medical technology sector secured more than EUR 2 billion in investment in 2021, with start-up companies and larger corporations alike developing great innovations.
Germany's life sciences sector was the top medical device FDI destination in 2019 and 2020. Companies including Bayer and BioNTech are also expanding their footprint in the country.
The coronavirus pandemic has given German biotechnology companies a massive boom. What does the state of the industry look like two years after the start of the crisis?
Germany's biotech firms are booming, innovations are being made using 3D printing and digital apps are an export hit in the thriving life sciences sector.
Strong demand for coronavirus vaccines is driving sales and production growth in Germany’s pharmaceutical industry.
MEDICA 2021, the world-leading information and communication platform for the medical technology industry and supplier industry took place entirely online as virtual.
Germany’s healthcare market is the largest in Europe, and the corona pandemic has given it a major boost.
The life sciences sector is carrying out mRNA-based research to develop vaccines for cancer, novel gene and cell therapies to treat Parkinson's, and providing a home for global pandemic research.